earnings
NV
NASDAQ · NVAX
Novavax, Inc.
Healthcare · Biotechnology
$9.23
Up+$0.12 (+1.30%)
Updated Sep 16, 2026, 8:56 PM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.09B
- P/E ratio
- 3.18
- Dividend yield
- 0.00%
- 52-week range
- $7.15 – $11.61
- Volume
- 3.33M
- Avg. volume
- 4.26M
Price performance
NVAX price history
1M range · 20 trading sessions · Daily adjusted prices
NVAX closed at $9.23 after 20 trading sessions, up 16.39% for the selected period.
- Last close
- $9.23
- Period change
- +16.39%
- Period low
- $7.93
- Period high
- $10.34
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $9.50 | $9.56 | $9.16 | $9.23 | 3.33M |
| Sep 14, 2026 | $9.38 | $9.60 | $9.135 | $9.59 | 3.37M |
| Sep 11, 2026 | $9.29 | $9.865 | $9.23 | $9.42 | 6.12M |
| Sep 10, 2026 | $9.64 | $9.68 | $9.11 | $9.30 | 5.89M |
| Sep 9, 2026 | $10.02 | $10.242 | $9.73 | $9.85 | 4.44M |
| Sep 8, 2026 | $10.099 | $10.3599 | $9.75 | $10.19 | 4.23M |
| Sep 4, 2026 | $10.50 | $10.7496 | $10.045 | $10.22 | 5.13M |
| Sep 3, 2026 | $10.415 | $10.48 | $9.9001 | $10.34 | 6.23M |
| Sep 2, 2026 | $10.275 | $10.73 | $9.96 | $10.32 | 5.64M |
| Sep 1, 2026 | $9.20 | $10.261 | $9.19 | $10.12 | 10.04M |
| Aug 31, 2026 | $9.10 | $9.985 | $9.09 | $9.37 | 7.27M |
| Aug 28, 2026 | $9.18 | $9.34 | $8.89 | $9.26 | 4.21M |
| Aug 27, 2026 | $9.12 | $9.18 | $8.915 | $9.05 | 3.43M |
| Aug 26, 2026 | $9.33 | $9.44 | $9.13 | $9.21 | 3.51M |
| Aug 25, 2026 | $9.07 | $9.58 | $8.93 | $9.44 | 7.11M |
| Aug 24, 2026 | $8.87 | $8.98 | $8.26 | $8.86 | 5.58M |
| Aug 21, 2026 | $8.44 | $9.1995 | $8.435 | $8.94 | 10.45M |
| Aug 20, 2026 | $8.50 | $8.66 | $8.02 | $8.42 | 5.98M |
| Aug 19, 2026 | $8.43 | $8.83 | $8.19 | $8.79 | 11.45M |
| Aug 18, 2026 | $7.97 | $8.08 | $7.835 | $7.93 | 2.02M |
Latest NVAX news
The latest Smart Investors Daily articles mentioning NVAX.
Stock researchCompany · Dividend
Loading stock research…